Literature DB >> 28963223

Complete Genome Sequences of Human Immunodeficiency Type 1 Viruses Genetically Engineered To Be Tropic for Rhesus Macaques.

Masako Nomaguchi1, Naoya Doi1, Takaaki Koma1, Akio Adachi2,3.   

Abstract

We have constructed two human immunodeficiency type 1 (HIV-1) derivatives, CXCR4 tropic and CCR5 tropic, that replicate in rhesus macaques. They are genetically engineered to be resistant to macaque restriction factors against HIV-1, including TRIM5α, APOBEC3, and tetherin proteins. The two HIV-1 variants described here are fundamental clones aiming for rhesus infection studies of HIV-1.
Copyright © 2017 Nomaguchi et al.

Entities:  

Year:  2017        PMID: 28963223      PMCID: PMC5624769          DOI: 10.1128/genomeA.01063-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Human immunodeficiency type 1 (HIV-1) is not infectious at all for a variety of small animal species widely used for experimental virus infections. Moreover, significant portions of basic and applied studies on HIV-1 have been hampered due to the lack of appropriate primates susceptible to this virus (1–3). Thus, in vivo model studies using HIV-1 itself and its susceptible hosts are currently thought to be implausible or extremely difficult. However, regardless of the above striking property of HIV-1, researchers, including us, have made efforts to establish primate models for HIV-1 infection by exquisitely modifying the HIV-1 genome, not by changing or genetically manipulating host animals. A common theme is the generation of macaque-tropic HIV-1s that are able to infect various species of macaques (4–9). HIV-1 is tropic for chimpanzees and humans and causes AIDS almost only in humans. Macaques, frequently used for primate studies of experimental virus infections, are not susceptible to HIV-1 at all. Although not completely elucidated yet, the remarkably narrow species tropism of HIV-1 has resulted mainly from cellular restriction factors against the virus (10–12), especially from TRIM5α and APOBEC3 proteins. Viral proteins that interact with and inactivate the TRIM5α and APOBEC3 proteins have been demonstrated to be Gag capsid and Vif, respectively. We and others have pioneered the genetic construction of HIV-1 with macaque tropism and successfully generated HIV-1 derivatives tropic for macaque cells by replacing the gag capsid and vif sequences with those of SIVmac239, a standard clone that replicates well in rhesus macaques and induces AIDS in infected animals (4, 5). These prototype macaque-tropic HIV-1 clones encode a complete Vif protein derived from SIVmac239 that is capable of degrading macaque APOBEC3 proteins, thus fully inactivating their antiviral activities (4, 5). However, macaque-tropic HIV-1 clones at that stage replicated much more poorly than the SIVmac239 clone, probably due to the insufficient modifications of the Gag capsid region. As surrogate animal models for studies on HIV-1 replication, HIV-1 pathogenesis, drug evaluation, and/or vaccine development, the rhesus macaque/SIVmac system has been frequently and successfully used. Taken together, we and others have recently generated novel versions of rhesus macaque-tropic HIV-1 (HIV-1rmt) clones through further alterations of the gag capsid region by various genetic methods (13, 14) and have obtained viruses that replicate in rhesus cells at a level comparable to that of SIVmac239 (13–15). We have also modified the viral vpu gene (14) to inactivate another cellular restriction factor tetherin that can contribute to the species tropism of HIV-1 (10–12). Indeed, our two new HIV-1rmt clones thus generated (14, 16) replicated considerably in rhesus macaques (our unpublished data). We sequenced full genomes of the two plasmid DNA clones, designated pMN4/LSDQgtu and pMN5/LSDQgtu, using an ABI Genetic Analyzer 3130xl (Thermo Fisher Scientific, USA) with a series of primers. Viruses derived from pMN4/LSDQgtu and pMN5/LSDQgtu are CXCR4 and CCR5 tropic, respectively, and are thus useful for various experimental analyses. These two macaque-tropic proviral clones lay valuable foundations for future HIV-1 model studies in primates.

Accession number(s).

The complete genome sequences of HIV-1rmt clones pMN4/LSDQgtu and pMN5/LSDQgtu have been deposited in DDBJ/EMBL/GenBank under accession numbers LC315178 and LC315179, respectively.
  15 in total

1.  Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques.

Authors:  Tatsuhiko Igarashi; Ranjini Iyengar; Russel A Byrum; Alicia Buckler-White; Robin L Dewar; Charles E Buckler; H Clifford Lane; Kazuya Kamada; Akio Adachi; Malcolm A Martin
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1.

Authors:  Rajesh Thippeshappa; Patricia Polacino; Monica T Yu Kimata; Edward B Siwak; David Anderson; Weiming Wang; Laura Sherwood; Reetakshi Arora; Michael Wen; Paul Zhou; Shiu-Lok Hu; Jason T Kimata
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 3.  The restriction factors of human immunodeficiency virus.

Authors:  Reuben S Harris; Judd F Hultquist; David T Evans
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

4.  Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.

Authors:  Kazuya Kamada; Tatsuhiko Igarashi; Malcolm A Martin; Boonruang Khamsri; Kazuki Hatcho; Tomoki Yamashita; Mikako Fujita; Tsuneo Uchiyama; Akio Adachi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-25       Impact factor: 11.205

5.  Generation of simian-tropic HIV-1 by restriction factor evasion.

Authors:  Theodora Hatziioannou; Michael Princiotta; Michael Piatak; Fang Yuan; Fengwen Zhang; Jeffrey D Lifson; Paul D Bieniasz
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

6.  Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications.

Authors:  Akatsuki Saito; Masako Nomaguchi; Sayuki Iijima; Ayumu Kuroishi; Tomoyuki Yoshida; Young-Jung Lee; Toshiyuki Hayakawa; Ken Kono; Emi E Nakayama; Tatsuo Shioda; Yasuhiro Yasutomi; Akio Adachi; Tetsuro Matano; Hirofumi Akari
Journal:  Microbes Infect       Date:  2010-10-16       Impact factor: 2.700

Review 7.  Species barrier of HIV-1 and its jumping by virus engineering.

Authors:  Masako Nomaguchi; Naoya Doi; Kazuya Kamada; Akio Adachi
Journal:  Rev Med Virol       Date:  2008 Jul-Aug       Impact factor: 6.989

8.  Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors.

Authors:  Masako Nomaguchi; Masaru Yokoyama; Ken Kono; Emi E Nakayama; Tatsuo Shioda; Naoya Doi; Sachi Fujiwara; Akatsuki Saito; Hirofumi Akari; Kei Miyakawa; Akihide Ryo; Hirotaka Ode; Yasumasa Iwatani; Tomoyuki Miura; Tatsuhiko Igarashi; Hironori Sato; Akio Adachi
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

9.  Growth potentials of CCR5-tropic/CXCR4-tropic HIV-1mt clones in macaque cells.

Authors:  Naoya Doi; Ayaka Okubo; Mizumo Yamane; Yosuke Sakai; Akio Adachi; Masako Nomaguchi
Journal:  Front Microbiol       Date:  2013-07-29       Impact factor: 5.640

10.  Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.

Authors:  Steven J Soll; Sam J Wilson; Sebla B Kutluay; Theodora Hatziioannou; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

View more
  1 in total

1.  CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques.

Authors:  Naoya Doi; Tomoyuki Miura; Hiromi Mori; Hiromi Sakawaki; Takaaki Koma; Akio Adachi; Masako Nomaguchi
Journal:  Front Microbiol       Date:  2018-10-18       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.